<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="other"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Gas Res</journal-id><journal-id journal-id-type="publisher-id">MGR</journal-id><journal-id journal-id-type="publisher-id">Med Gas Res</journal-id><journal-title-group><journal-title>Medical Gas Research</journal-title></journal-title-group><issn pub-type="epub">2045-9912</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC466990</article-id><article-id pub-id-type="publisher-id">MGR-14-142</article-id><article-id pub-id-type="doi">10.4103/2045-9912.385941</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Nitrous oxide induces subacute combined degeneration by affecting vitamin B12 metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Weiliang</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wenjie</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yang</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xuejian</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhao</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Jinjie</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yi</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Zhifeng</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-9375-3906</contrib-id><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff1">Department of Neurosurgery, Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China</aff><author-notes><corresp id="cor1"><label>*</label><italic toggle="yes"><bold>Correspondence to:</bold> Zhifeng Wang, <email xlink:href="maisui1976@163.com">maisui1976@163.com</email></italic>.</corresp><fn id="fn1"><label>#</label><p>Both authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="collection"><season>Jul-Sep</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>9</month><year>2023</year></pub-date><volume>14</volume><issue>3</issue><fpage>142</fpage><lpage>144</lpage><history><date date-type="received"><day>02</day><month>4</month><year>2022</year></date><date date-type="rev-recd"><day>09</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>14</day><month>6</month><year>2023</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2024 Medical Gas Research</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Historical documents give inconsistent statements about the timing of the separation of nitrous oxide (N<sub>2</sub>O). The first synthesis of N<sub>2</sub>O is generally believed to have been made by Joseph Priestley in 1776.<xref rid="R1" ref-type="bibr">1</xref><xref rid="R2" ref-type="bibr">2</xref><xref rid="R3" ref-type="bibr">3</xref> By 1793, Dr. Thomas Cochrane had moved from Oxford to Brisbane, where he established pneumatic mechanisms including N<sub>2</sub>O.<xref rid="R1" ref-type="bibr">1</xref><xref rid="R4" ref-type="bibr">4</xref> Subsequently, Humphrey Davy discovered that N<sub>2</sub>O can reduce pain during the surgery and gave an extensive N<sub>2</sub>O lecture. In 1844, Horace Wells realized that the gas could be used as an anesthetic<xref rid="R5" ref-type="bibr">5</xref> and extracted one of his molars under N<sub>2</sub>O anesthesia. N<sub>2</sub>O played an important role in dentistry after the 1870s, and subsequently, in the 1930s, N<sub>2</sub>O became the mainstay of intrapartum pain relief. N<sub>2</sub>O was invented by European scientists in the 18<sup>th</sup> and 19<sup>th</sup> centuries and has been used as an anesthetic for over 150 years.<xref rid="R6" ref-type="bibr">6</xref></p><p>N<sub>2</sub>O is used clinically as a safe anesthetic, especially in dentistry and pregnancy, while in other respects, according to the literature, N<sub>2</sub>O shows early promise as a rapid antidepressant in patients with the treatment-resistant major depressive disorder.<xref rid="R7" ref-type="bibr">7</xref><xref rid="R8" ref-type="bibr">8</xref> The neuroprotective effect of N<sub>2</sub>O on cerebral ischemia/reperfusion,<xref rid="R9" ref-type="bibr">9</xref> N<sub>2</sub>O did not improve the neuroprotective effect after cerebral ischemia/reperfusion. Ischemic stroke is the most common cerebrovascular accident with high morbidity and mortality,<xref rid="R10" ref-type="bibr">10</xref> but the incidence of subacute comorbid myelopathy is also increasing, and N<sub>2</sub>O reuptake has increased in the adolescent population in recent years.<xref rid="R11" ref-type="bibr">11</xref> Global Drug Survey 2012, an international online survey of young people, with more than 22,000 respondents reported that nearly half of UK respondents had used N<sub>2</sub>O repeatedly at some point, 10% in the past 12 months.<xref rid="R12" ref-type="bibr">12</xref> In the 2016 Global Toxicology Survey, N<sub>2</sub>O accounted for 8.7%<xref rid="R13" ref-type="bibr">13</xref> and was the second most common drug in this age group. N<sub>2</sub>O is a very commonly used drug, especially in the United Kingdom and the United States (lifetime prevalence rates of 38.6% and 29.4%).<xref rid="R14" ref-type="bibr">14</xref> The number of published papers and related patients has increased rapidly every year since the first case was reported in China in 2016.<xref rid="R15" ref-type="bibr">15</xref> In conclusion, the use of N<sub>2</sub>O outside of hospitals is gradually increasing, especially among adolescents.</p><p><bold>Clinical manifestations and mechanisms:</bold> The clinical manifestations of subacute combined degeneration (SCD) caused by N<sub>2</sub>O abuse are nonspecific and are mainly divided into chronic and subacute onset. Low doses of N<sub>2</sub>O can produce pleasurable sensations and even hallucinations, but these disappear quickly. Of course, all patients with N<sub>2</sub>O abuse experience symptoms of neurotoxicity, mainly including numbness and weakness of the limbs and decreased sensation, autonomic dysfunction, and cognitive impairment. The mechanism by which N<sub>2</sub>O abuse causes SCD remains unclear but appears to be due to vitamin B12 deficiency.<xref rid="R16" ref-type="bibr">16</xref> Long-term inhalation of N<sub>2</sub>O can interfere with the metabolism of vitamin B12 and may cause pathological changes due to its deficiency.<xref rid="R17" ref-type="bibr">17</xref> With prolonged inhalation time and increased inhalation volume, N<sub>2</sub>O will oxidize cobalt ions, resulting in vitamin B12 as a coenzyme inactivation of metabolic processes (<bold><xref rid="F1" ref-type="fig">Figure 1</xref></bold>),<xref rid="R18" ref-type="bibr">18</xref> preventing homocysteine from being converted to methionine, and methylmalonyl-coenzyme A cannot be isomerized to succinyl-coenzyme A,<xref rid="R19" ref-type="bibr">19</xref> resulting in degeneration of the central nervous system and formation of SCD in the myelin sheath and spine.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Simplified diagram of increased homocysteine and methyl-malonic acid levels due to inactivation of vitamin B12.</p><p>Note: Created with BioRender.com. CoA: Coenzyme A; MMA: methylmalonic acid.</p></caption><graphic xlink:href="MGR-14-142-g001" position="float"/></fig><p><bold>Diagnosis, treatment, and prognosis:</bold> Diagnosis and differential diagnosis are usually based on the patient&#x02019;s clinical manifestations, biochemical tests, and imaging studies. Biochemical tests show mainly a decrease in vitamin B12, an increase in methylmalonic acid and homocysteine,<xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr">22</xref> and magnetic resonance imaging (MRI) showed an abnormal T2-weighted signal in the spine.<xref rid="R23" ref-type="bibr">23</xref> Cessation of N<sub>2</sub>O and oral or intramuscular vitamin B12 supplementation are the mainstays of treatment,<xref rid="R24" ref-type="bibr">24</xref> and with reasonable treatment, neurological symptoms may take months to resolve, and many patients report residual symptoms.<xref rid="R14" ref-type="bibr">14</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref> The speed and extent of recovery are inversely correlated with N<sub>2</sub>O intake and the extent of the spinal cord and peripheral nerve damage.</p><p><bold>Methods:</bold> Using &#x0201c;nitrous oxide (N<sub>2</sub>O)&#x0201d; and/or &#x0201c;subacute combined degeneration (SCD)&#x0201d; as the keywords, a literature search was conducted through the PubMed database with the following inclusion criteria: (1) literature case reports from 2015 to 2020; (2) history of N<sub>2</sub>O abuse; (3) age &#x02265; 18 years old; (4) have neurological signs and symptoms; (5) exclude other diseases that lead to decreased vitamin B12, such as autoimmune gastritis, congenital vitamin B12 deficiency, and folic acid deficiency; (6) only cases reported in English. The clinical manifestations, physical examination, biochemical examination, imaging examination, treatment, and prognosis were analyzed for the eligible cases. The case report was approved by Ethics Committee of Nantong First People&#x02019;s Hospital (No. 2023KT102) and obtained written informed consent from each patient.</p><p><bold>Case report:</bold> We included 16 N<sub>2</sub>O abusers from 2015 to 2020 (<bold><xref rid="T1" ref-type="table">Additional Table 1</xref></bold>), all of whom were adolescents and had prominent neurological symptoms at the onset of symptoms, the most common being numbness, weakness, and motor paresthesia. Neurological examinations mainly indicated Romberg&#x02019;s sign positive, Babinski&#x02019;s sign positive, and Brudzinski&#x02019;s sign positive. Biochemical tests indicated decreased vitamin B12, with or without increased methylmalonic acid and (or) homocysteine levels. A small number of patients developed megaloblastic anemia. On imaging, MRI T2 signals showed varying degrees of hyperdensity in the spine, with an inverted V or &#x0201c;rabbit ear&#x0201d; sign on cervical MRI in some patients. Treatment mainly included discontinuation of N<sub>2</sub>O and oral or intramuscular injection of vitamin B12. The serum vitamin B12 level of the patient improved rapidly, and neurological symptoms also recovered to varying degrees.</p><table-wrap position="float" id="T1"><label>Additional Table 1</label><caption><p>Clinical characteristics, treatment and prognosis of 16 patients with nitrous oxide (N<sub>2</sub>O) abuse</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Patient No.</th><th align="left" rowspan="1" colspan="1">Age/sex</th><th align="left" rowspan="1" colspan="1">Date</th><th align="left" rowspan="1" colspan="1">Symptoms</th><th align="left" rowspan="1" colspan="1">N2O abuse</th><th align="left" rowspan="1" colspan="1">Neurological examination</th><th align="left" rowspan="1" colspan="1">Vit. B12</th><th align="left" rowspan="1" colspan="1">HCY</th><th align="left" rowspan="1" colspan="1">Spinal MRI changes</th><th align="left" rowspan="1" colspan="1">Treatment</th><th align="left" rowspan="1" colspan="1">Prognosis</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1<xref rid="R1a" ref-type="bibr">1</xref></td><td align="left" rowspan="1" colspan="1">27/F</td><td align="left" rowspan="1" colspan="1">2015</td><td align="left" rowspan="1" colspan="1">LN+LW</td><td align="left" rowspan="1" colspan="1">3 years</td><td align="left" rowspan="1" colspan="1">R (+)</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">C3-T12</td><td align="left" rowspan="1" colspan="1">1000 mg of cyanocobalamin was injected daily for 5 days, and then 1000 mg per week for 4 weeks</td><td align="left" rowspan="1" colspan="1">Stable discharge after 3 days</td></tr><tr><td align="left" rowspan="1" colspan="1">2<xref rid="R2a" ref-type="bibr">2</xref></td><td align="left" rowspan="1" colspan="1">20/F</td><td align="left" rowspan="1" colspan="1">2017</td><td align="left" rowspan="1" colspan="1">LN+LW+H</td><td align="left" rowspan="1" colspan="1">1 year</td><td align="left" rowspan="1" colspan="1">R (+); BA (+); MMSE (23)</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">C1-T2</td><td align="left" rowspan="1" colspan="1">Vitamin B12 injections (1 mg per day) and the cessation of N<sub>2</sub>O exposure</td><td align="left" rowspan="1" colspan="1">After 3 months, the sensory and gait symptoms were significantly relieved and the cognitive function was completely recovered</td></tr><tr><td align="left" rowspan="1" colspan="1">3<xref rid="R3a" ref-type="bibr">3</xref></td><td align="left" rowspan="1" colspan="1">20/M</td><td align="left" rowspan="1" colspan="1">2018</td><td align="left" rowspan="1" colspan="1">LN+H</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">Patellar emission (+); Tendon hyperreflexia</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">C2-C4</td><td align="left" rowspan="1" colspan="1">Active vitamin B12 supplementation (dose unknown)</td><td align="left" rowspan="1" colspan="1">The symptoms were relieved after 4 months</td></tr><tr><td align="left" rowspan="1" colspan="1">4<xref rid="R4a" ref-type="bibr">4</xref></td><td align="left" rowspan="1" colspan="1">29/F</td><td align="left" rowspan="1" colspan="1">2018</td><td align="left" rowspan="1" colspan="1">LW</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">BA (+);</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">T4</td><td align="left" rowspan="1" colspan="1">Stop using N<sub>2</sub>O and vitamin B12 replacement therapy</td><td align="left" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="left" rowspan="1" colspan="1">5<xref rid="R5a" ref-type="bibr">5</xref></td><td align="left" rowspan="1" colspan="1">24/M</td><td align="left" rowspan="1" colspan="1">2018</td><td align="left" rowspan="1" colspan="1">LN+LW</td><td align="left" rowspan="1" colspan="1">5 months</td><td align="left" rowspan="1" colspan="1">R (+); Deep hypoesthesia of foot</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">&#x02191;</td><td align="left" rowspan="1" colspan="1">C1-C7</td><td align="left" rowspan="1" colspan="1">Vitamin B12 1mg was injected every day for more than 1 week</td><td align="left" rowspan="1" colspan="1">Paresthesia improved and ataxia partially improved</td></tr><tr><td align="left" rowspan="1" colspan="1">6<xref rid="R5a" ref-type="bibr">5</xref></td><td align="left" rowspan="1" colspan="1">22/F</td><td align="left" rowspan="1" colspan="1">2018</td><td align="left" rowspan="1" colspan="1">LN+LW</td><td align="left" rowspan="1" colspan="1">3 months</td><td align="left" rowspan="1" colspan="1">Inferior muscle strength level II; R(DU);</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">&#x02191;</td><td align="left" rowspan="1" colspan="1">C1-C7</td><td align="left" rowspan="1" colspan="1">1 mg of vitamin B12 was injected intramuscularly for 2 weeks and at the outpatient clinic every 2 weeks for 4 weeks</td><td align="left" rowspan="1" colspan="1">Three months later, the proprioception of the upper limbs was normal and the proprioception of the lower limbs was improved. Sensory abnormalities of lower limbs were further improved, and dysuria was also partially improved</td></tr><tr><td align="left" rowspan="1" colspan="1">7<xref rid="R6a" ref-type="bibr">6</xref></td><td align="left" rowspan="1" colspan="1">19/F</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">LW</td><td align="left" rowspan="1" colspan="1">A few weeks</td><td align="left" rowspan="1" colspan="1">Left upper extremity hyperreflexia</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">C3-C6</td><td align="left" rowspan="1" colspan="1">Intramuscular injection of vitamin B12</td><td align="left" rowspan="1" colspan="1">Transferred to a hospital in China for continuous rehabilitation</td></tr><tr><td align="left" rowspan="1" colspan="1">8<xref rid="R6a" ref-type="bibr">6</xref></td><td align="left" rowspan="1" colspan="1">19/F</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">6 months</td><td align="left" rowspan="1" colspan="1">Gait and trunk ataxia</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">C1-C7</td><td align="left" rowspan="1" colspan="1">Vitamin B12 replacement therapy</td><td align="left" rowspan="1" colspan="1">Transferred to a spinal rehabilitation institution in China</td></tr><tr><td align="left" rowspan="1" colspan="1">9<xref rid="R6a" ref-type="bibr">6</xref></td><td align="left" rowspan="1" colspan="1">18/F</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">LN+LW</td><td align="left" rowspan="1" colspan="1">9 months</td><td align="left" rowspan="1" colspan="1">Hyperthyroidism of upper and lower limbs</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">C1-T12</td><td align="left" rowspan="1" colspan="1">Vitamin B12 replacement therapy</td><td align="left" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="left" rowspan="1" colspan="1">10<xref rid="R7a" ref-type="bibr">7</xref></td><td align="left" rowspan="1" colspan="1">22/F</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">LN+LW</td><td align="left" rowspan="1" colspan="1">6 months</td><td align="left" rowspan="1" colspan="1">R(+);</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">C1-C7</td><td align="left" rowspan="1" colspan="1">They were treated with daily intramuscular cobalamin (1 mg) for 2 weeks, followed by oral medication</td><td align="left" rowspan="1" colspan="1">Neurological function improved gradually</td></tr><tr><td align="left" rowspan="1" colspan="1">11<xref rid="R7a" ref-type="bibr">7</xref></td><td align="left" rowspan="1" colspan="1">33/M</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">LW+LW</td><td align="left" rowspan="1" colspan="1">4 months</td><td align="left" rowspan="1" colspan="1">R (+)</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">C1-C7</td><td align="left" rowspan="1" colspan="1">They were treated with daily intramuscular cobalamin (1 mg) for 2 weeks, followed by oral medication</td><td align="left" rowspan="1" colspan="1">Neurological function improved gradually</td></tr><tr><td align="left" rowspan="1" colspan="1">12<xref rid="R8a" ref-type="bibr">8</xref></td><td align="left" rowspan="1" colspan="1">22/M</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">LW</td><td align="left" rowspan="1" colspan="1">4 months</td><td align="left" rowspan="1" colspan="1">hypertonicity; hyperreflexia</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">DU</td><td align="left" rowspan="1" colspan="1">C1-C6</td><td align="left" rowspan="1" colspan="1">Take high-dose vitamin B12 and inject 1 mg intramuscularly every day</td><td align="left" rowspan="1" colspan="1">After the 7<sup>th</sup> day, the nervous system improved</td></tr><tr><td align="left" rowspan="1" colspan="1">13<xref rid="R9a" ref-type="bibr">9</xref></td><td align="left" rowspan="1" colspan="1">24/M</td><td align="left" rowspan="1" colspan="1">2020</td><td align="left" rowspan="1" colspan="1">LW+LW</td><td align="left" rowspan="1" colspan="1">3 months</td><td align="left" rowspan="1" colspan="1">R (+); BA (+);</td><td align="left" rowspan="1" colspan="1">&#x02193;</td><td align="left" rowspan="1" colspan="1">&#x02191;</td><td align="left" rowspan="1" colspan="1">C2-C6</td><td align="left" rowspan="1" colspan="1">High dose supplementation with intramuscular vitamin B12 (1.5 mg per day), oral folic acid (15 mg per day), and N<sub>2</sub>O withdrawal</td><td align="left" rowspan="1" colspan="1">After 1 month, the symptoms of weakness and paresthesia were relieved</td></tr><tr><td align="left" rowspan="1" colspan="1">14<xref rid="R10a" ref-type="bibr">10</xref></td><td align="left" rowspan="1" colspan="1">18/F</td><td align="left" rowspan="1" colspan="1">2020</td><td align="left" rowspan="1" colspan="1">LW+LW</td><td align="left" rowspan="1" colspan="1">1 month</td><td align="left" rowspan="1" colspan="1">Limb muscle strength (&#x02193;)</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">&#x02191;</td><td align="left" rowspan="1" colspan="1">T3-T6</td><td align="left" rowspan="1" colspan="1">Stop inhaling N<sub>2</sub>O and smoking, supplement Mecobalamin capsule (500 &#x003bc; g three times a day), compound vitamin B (one tablet three times a day), and rehabilitation treatment for 1 mon</td><td align="left" rowspan="1" colspan="1">The symptoms completely disappeared 9 mon after discharge</td></tr><tr><td align="left" rowspan="1" colspan="1">15<xref rid="R10a" ref-type="bibr">10</xref></td><td align="left" rowspan="1" colspan="1">21/M</td><td align="left" rowspan="1" colspan="1">2020</td><td align="left" rowspan="1" colspan="1">LN+LW</td><td align="left" rowspan="1" colspan="1">1 month</td><td align="left" rowspan="1" colspan="1">R (+); BA (+);</td><td align="left" rowspan="1" colspan="1">&#x02191;</td><td align="left" rowspan="1" colspan="1">&#x02191;</td><td align="left" rowspan="1" colspan="1">C2-C6</td><td align="left" rowspan="1" colspan="1">Stop inhaling N2O, Mecobalamin capsule (500 mg three times a day), vitamin B complex (one tablet three times a day), and rehabilitation treatment, and start the treatment for 23 d</td><td align="left" rowspan="1" colspan="1">Numbness symptoms have improved, but the patient still difficult to walk independently. He can walk independently 4 mon after discharge</td></tr><tr><td align="left" rowspan="1" colspan="1">16<xref rid="R11a" ref-type="bibr">11</xref></td><td align="left" rowspan="1" colspan="1">22/M</td><td align="left" rowspan="1" colspan="1">2020</td><td align="left" rowspan="1" colspan="1">LN+LW</td><td align="left" rowspan="1" colspan="1">3 years</td><td align="left" rowspan="1" colspan="1">HO (+); R (+);</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">C1-C7</td><td align="left" rowspan="1" colspan="1">Intramuscular injection of hydroxocobalamin lasted for 3 mon</td><td align="left" rowspan="1" colspan="1">After 5 d, the divine function was partially restored</td></tr></tbody></table><table-wrap-foot><fn id="TF-F1"><p>Note: &#x0201c;&#x02191;&#x0201d;: Up; &#x0201c;&#x02193;&#x0201d;: down; BA: Babinski sign; BR: Brudzinski sign; DU: details unknown; F: female; H: hypoesthesia; HCY: homocysteine; HO: Hoffmann sign; LN: limb numbness; LW: limb weakness; M: male; MMSE: Mini-Mental State Examination; MRI: magnetic resonance imaging; N: normal; R: Romberg sign; Vit.: vitamin.</p></fn></table-wrap-foot></table-wrap><p><bold>Discussion:</bold> With the increase in N<sub>2</sub>O use in adolescents, the incidence of SCD gradually increases. Why does excessive N2O cause SCD? The pathogenic mechanism of N<sub>2</sub>O remains unclear, and numerous studies have shown that N<sub>2</sub>O oxidizes cobalt ions in vitamin B12, rendering it inactive.<xref rid="R27" ref-type="bibr">27</xref> Cobalamin is mainly used as an enzyme cofactor in the human body. Inactive cobalamin prevents the body from synthesizing succinyl-coenzyme A and methionine, which are essential for the methylation of myelin sheaths, thus, leading to demyelination of the nervous system.<xref rid="R28" ref-type="bibr">28</xref> Furthermore, serum homocysteine in patients with N<sub>2</sub>O abuse is closely associated with nail thrombosis.<xref rid="R29" ref-type="bibr">29</xref></p><p><bold><xref rid="T1" ref-type="table">Additional Table 1</xref></bold> shows 17 patients, all of whom ingested N<sub>2</sub>O for at least several weeks to as long as 3 years. These adolescents obtained N O because small N O steel tanks were sold in 22 foreign supermarkets as a food additive, resulting in the foaming structure of fresh milk powder,<xref rid="R30" ref-type="bibr">30</xref> while N<sub>2</sub>O is readily available, cheap, and legal in adolescents and thus cannot be detected in routine positive drug screening. When adolescents inhale N<sub>2</sub>O, the partial pressure of N<sub>2</sub>O first increases in the lungs and then increases in the blood. N<sub>2</sub>O acts quickly after inhalation for a few seconds, and its high elimination rate makes the patient return to normal quickly. The gas, N<sub>2</sub>O, has minimal short-term effects on heart function, making it considered safe for adolescents. This is due to its quick and complete elimination from the body after inhalation. However, a potential concern is that adolescents may not recognize the side effects of N<sub>2</sub>O and may consume it for extended periods of time. And yet another recent lockdown due to the coronavirus disease 2019 pandemic was associated with higher rates of psychiatric symptoms and substance abuse,<xref rid="R31" ref-type="bibr">31</xref> including N<sub>2</sub>O use.</p><p>In the majority of patients with a history of N<sub>2</sub>O abuse and neurological symptoms consistent with it, the diagnosis is relatively straightforward, but clinically it is also crucial to emphasize the consideration of N<sub>2</sub>O abuse in the differential diagnosis because some patients have atypical neurological signs and symptoms. A normal serum vitamin B12 level does not indicate accurate or timely cellular availability of vitamin B12,<xref rid="R32" ref-type="bibr">32</xref> as N<sub>2</sub>O causes vitamin B12 inactivation rather than a true deficiency. In addition to patients with reduced vitamin B12, there are other factors that can cause a decrease in vitamin B12 levels, including metabolic diseases, inflammatory infections, and tumors. It is essential to identify and diagnose these underlying diseases. Differential diagnosis of diseases that lead to vitamin B12 reduction, such as advanced deficiency, requires all clinicians to perform additional differential diagnostic tests, such as checking the patient&#x02019;s homocysteine and methylmalonic acid levels. It is used to check the differential diagnosis of spinal cord MRI and other semen lesions, such as neurosarcoidosis, central and peripheral neuropathy caused by acquired immune deficiency syndrome and syphilis, peripheral nerve vasculitis, etc. Classical SCD lesions are hyperintense on posterolateral T2-weighted spinal cord and can appear as an inverted V shape on axial MRI,<xref rid="R33" ref-type="bibr">33</xref><xref rid="R34" ref-type="bibr">34</xref> but only half of the patients with N<sub>2</sub>O-related spinal cord subacute lesions have MRI abnormalities. Therefore, to diagnose a patient, we should perform a physical examination. According to the main symptoms of the patient, the etiology of subacute spinal cord lesions was excluded, and comprehensive judgment was made based on biochemical examination and imaging examination.</p><p><bold>Conclusion:</bold> Taken together, N<sub>2</sub>O abuse mostly leads to subacute lesions of the spinal cord, mainly manifested as limb weakness, dyskinesia, and paresthesia, accompanied by decreased serum vitamin B12 and abnormal T2 signal high density in the posterior and lateral columns of the spinal cord. Among these people who abuse N<sub>2</sub>O, the main group is adolescents, which is related to their lack of awareness of the harm of N<sub>2</sub>O and national policies.</p><p><italic toggle="yes">This work was supported by Research Project of Nantong Municipal Health Commission, No. MB2021027, and Research Project of Kangda College, Nanjing Medical University, No. KD2022KYJJZD019</italic>.</p><sec sec-type="supplementary-material"><title>Additional file</title><p><bold><italic toggle="yes"><xref rid="T1" ref-type="table">Additional Table 1</xref>:</italic></bold>
<italic toggle="yes">Clinical characteristics, treatment and prognosis of 16 patients with nitrous oxide abuse</italic>.</p></sec></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buslov</surname><given-names>A</given-names></name>
<name><surname>Carroll</surname><given-names>M</given-names></name>
<name><surname>Desai</surname><given-names>MS</given-names></name></person-group><article-title>Frozen in time: a history of the synthesis of nitrous oxide and how the process remained unchanged for over 2 centuries</article-title><source>Anesth Analg</source><year>2018</year><volume>127</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">29782399</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>WD</given-names></name></person-group><article-title>A history of nitrous oxide and oxygen anaesthesia. IA. The discovery of nitrous oxide and of oxygen</article-title><source>Br J Anaesth</source><year>1972</year><volume>44</volume><fpage>297</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">4552910</pub-id>
</element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lew</surname><given-names>V</given-names></name>
<name><surname>McKay</surname><given-names>E</given-names></name>
<name><surname>Maze</surname><given-names>M</given-names></name></person-group><article-title>Past, present, and future of nitrous oxide</article-title><source>Br Med Bull</source><year>2018</year><volume>125</volume><fpage>103</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">29528367</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Levere</surname><given-names>TH</given-names></name></person-group><article-title>Dr. Thomas Beddoes and the establishment of his pneumatic institution: a tale of three presidents</article-title><source>Notes Rec R Soc Lond</source><year>1977</year><volume>32</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">11615622</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gillman</surname><given-names>MA</given-names></name></person-group><article-title>Mini-Review: A brief history of nitrous oxide (N<sub>2</sub>O) use in neuropsychiatry</article-title><source>Curr Drug Res Rev</source><year>2019</year><volume>11</volume><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">30829177</pub-id>
</element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schwilden</surname><given-names>H</given-names></name>
<name><surname>Sch&#x000fc;ttler</surname><given-names>J</given-names></name></person-group><article-title>200 years of nitrous oxide (laughing gas)--and the end of an era?</article-title><source>Anasthesiol Intensivmed Notfallmed Schmerz-ther</source><year>2001</year><volume>36</volume><fpage>640</fpage></element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nagele</surname><given-names>P</given-names></name>
<name><surname>Zorumski</surname><given-names>CF</given-names></name>
<name><surname>Conway</surname><given-names>C</given-names></name></person-group><article-title>Exploring nitrous oxide as treatment of mood disorders: basic concepts</article-title><source>J Clin Psychopharmacol</source><year>2018</year><volume>38</volume><fpage>144</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">29360650</pub-id>
</element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nagele</surname><given-names>P</given-names></name>
<name><surname>Duma</surname><given-names>A</given-names></name>
<name><surname>Kopec</surname><given-names>M</given-names></name>
<etal/></person-group><article-title>Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial</article-title><source>Biol Psychiatry</source><year>2015</year><volume>78</volume><fpage>10</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">25577164</pub-id>
</element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoffmann</surname><given-names>U</given-names></name>
<name><surname>Sheng</surname><given-names>H</given-names></name>
<name><surname>Ayata</surname><given-names>C</given-names></name>
<name><surname>Warner</surname><given-names>DS</given-names></name></person-group><article-title>Anesthesia in experimental stroke research</article-title><source>Transl Stroke Res</source><year>2016</year><volume>7</volume><fpage>358</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">27534542</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>T</given-names></name>
<name><surname>Zhu</surname><given-names>T</given-names></name>
<name><surname>Xie</surname><given-names>L</given-names></name>
<etal/></person-group><article-title>Neural stem cells therapy for ischemic stroke: progress and challenges</article-title><source>Transl Stroke Res</source><year>2022</year><volume>13</volume><fpage>665</fpage><lpage>675</lpage><pub-id pub-id-type="pmid">35032307</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Domont</surname><given-names>P</given-names></name>
<name><surname>Debaize</surname><given-names>S</given-names></name></person-group><article-title>Extra hospital use of nitrous oxide for recreational purposes</article-title><source>Rev Prat</source><year>2020</year><volume>70</volume><fpage>1143</fpage><lpage>1149</lpage><pub-id pub-id-type="pmid">33739664</pub-id>
</element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Winstock</surname><given-names>AR</given-names></name>
<name><surname>Griffiths</surname><given-names>P</given-names></name>
<name><surname>Stewart</surname><given-names>D</given-names></name></person-group><article-title>Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK</article-title><source>Drug Alcohol Depend</source><year>2001</year><volume>64</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">11470336</pub-id>
</element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="webpage"><collab>GOV.UK</collab><article-title>Drug misuse: findings from the 2018 to 2019 CSEW</article-title><comment><uri xlink:href="https://www.gov.uk/government/statistics/drug-misuse-findings-from-the-2018-to-2019-csew">https://www.gov.uk/government/statistics/drug-misuse-findings-from-the-2018-to-2019-csew</uri>. Accessed March 11, 2020</comment></element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaar</surname><given-names>SJ</given-names></name>
<name><surname>Ferris</surname><given-names>J</given-names></name>
<name><surname>Waldron</surname><given-names>J</given-names></name>
<name><surname>Devaney</surname><given-names>M</given-names></name>
<name><surname>Ramsey</surname><given-names>J</given-names></name>
<name><surname>Winstock</surname><given-names>AR</given-names></name></person-group><article-title>Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use</article-title><source>J Psychopharmacol</source><year>2016</year><volume>30</volume><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">26912510</pub-id>
</element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>D</given-names></name>
<name><surname>Ba</surname><given-names>F</given-names></name>
<name><surname>Bi</surname><given-names>G</given-names></name>
<name><surname>Guo</surname><given-names>Y</given-names></name>
<name><surname>Gao</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>W</given-names></name></person-group><article-title>The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature</article-title><source>J Neurol</source><year>2020</year><volume>267</volume><fpage>422</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">31655888</pub-id>
</element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agarwal</surname><given-names>P</given-names></name>
<name><surname>Khor</surname><given-names>SY</given-names></name>
<name><surname>Do</surname><given-names>S</given-names></name>
<name><surname>Charles</surname><given-names>L</given-names></name>
<name><surname>Tikaria</surname><given-names>R</given-names></name></person-group><article-title>Recreational nitrous oxide-induced subacute combined degeneration of the spinal cord</article-title><source>Cu-reus</source><year>2021</year><volume>13</volume><fpage>e19377</fpage></element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hathout</surname><given-names>L</given-names></name>
<name><surname>El-Saden</surname><given-names>S</given-names></name></person-group><article-title>Nitrous oxide-induced B12 deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B12</article-title><source>J Neurol Sci</source><year>2011</year><volume>301</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21112598</pub-id>
</element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vall&#x000e8;s</surname><given-names>M</given-names></name>
<name><surname>Soler</surname><given-names>D</given-names></name>
<name><surname>Albu</surname><given-names>S</given-names></name>
<name><surname>Kumru</surname><given-names>H</given-names></name></person-group><article-title>Neurological complications of nitrous oxide consumption. A case report</article-title><source>Rev Neurol</source><year>2021</year><volume>72</volume><fpage>261</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">33764495</pub-id>
</element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Al-Sadawi</surname><given-names>M</given-names></name>
<name><surname>Claris</surname><given-names>H</given-names></name>
<name><surname>Archie</surname><given-names>C</given-names></name>
<name><surname>Jayarangaiah</surname><given-names>A</given-names></name>
<name><surname>Oluya</surname><given-names>M</given-names></name>
<name><surname>McFar-lane</surname><given-names>SI</given-names></name></person-group><article-title>Inhaled nitrous oxide &#x02018;whip-its!&#x02019; causing subacute combined degeneration of spinal cord</article-title><source>Am J Med Case Rep</source><year>2018</year><volume>6</volume><fpage>237</fpage><lpage>240</lpage></element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Saji</surname><given-names>AM</given-names></name>
<name><surname>De Jesus</surname><given-names>O</given-names></name></person-group><source>Spinal cord subacute combined degeneration</source><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2023</year></element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Temple</surname><given-names>C</given-names></name>
<name><surname>Horowitz</surname><given-names>BZ</given-names></name></person-group><article-title>Nitrous oxide abuse induced subacute combined degeneration despite patient initiated B12 supplementation</article-title><source>Clin Toxicol (Phila)</source><year>2022</year><volume>60</volume><fpage>872</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">35253567</pub-id>
</element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bao</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>Q</given-names></name>
<name><surname>Li</surname><given-names>Q</given-names></name>
<etal/></person-group><article-title>Clinical, Electrophysiological and radiological features of nitrous oxide-induced neurological disorders</article-title><source>Neuropsychi-atr Dis Treat</source><year>2020</year><volume>16</volume><fpage>977</fpage><lpage>984</lpage></element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Check</surname><given-names>L</given-names></name>
<name><surname>Abdelsayed</surname><given-names>N</given-names></name>
<name><surname>Figueroa</surname><given-names>G</given-names></name>
<name><surname>Ragunathan</surname><given-names>A</given-names></name>
<name><surname>Faris</surname><given-names>M</given-names></name></person-group><article-title>Subacute combined degeneration of the cervical spine secondary to inhaled nitrous-oxide-induced cobalamin deficiency</article-title><source>Cureus</source><year>2022</year><volume>14</volume><fpage>e21214</fpage><pub-id pub-id-type="pmid">35174022</pub-id>
</element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shah</surname><given-names>K</given-names></name>
<name><surname>Murphy</surname><given-names>C</given-names></name></person-group><article-title>Nitrous oxide toxicity: case files of the carolinas medical center medical toxicology fellowship</article-title><source>J Med Toxicol</source><year>2019</year><volume>15</volume><fpage>299</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">31388940</pub-id>
</element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Winstock</surname><given-names>AR</given-names></name>
<name><surname>Ferris</surname><given-names>JA</given-names></name></person-group><article-title>Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users</article-title><source>J Psychopharma-col</source><year>2020</year><volume>34</volume><fpage>229</fpage><lpage>236</lpage></element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>AG</given-names></name>
<name><surname>Leite</surname><given-names>MI</given-names></name>
<name><surname>Lunn</surname><given-names>MP</given-names></name>
<name><surname>Bennett</surname><given-names>DL</given-names></name></person-group><article-title>Whippits, nitrous oxide and the dangers of legal highs</article-title><source>Pract Neurol</source><year>2015</year><volume>15</volume><fpage>207</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25977272</pub-id>
</element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Edirisinghe</surname><given-names>SP</given-names></name></person-group><article-title>Homocysteine-induced thrombosis</article-title><source>Br J Biomed Sci</source><year>2004</year><volume>61</volume><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">15058745</pub-id>
</element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>HM</given-names></name>
<name><surname>Park</surname><given-names>JH</given-names></name>
<name><surname>Hernstadt</surname><given-names>D</given-names></name></person-group><article-title>Subacute combined degeneration of the spinal cord following recreational nitrous oxide use</article-title><source>BMJ Case Rep</source><year>2013</year><fpage>2013</fpage></element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Norris</surname><given-names>F</given-names></name>
<name><surname>Mallia</surname><given-names>P</given-names></name></person-group><article-title>Lesson of the month 2: A case of nitrous oxide-induced pancytopenia</article-title><source>Clin Med (Lond)</source><year>2019</year><volume>19</volume><fpage>129</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">30872294</pub-id>
</element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Einsiedler</surname><given-names>M</given-names></name>
<name><surname>Voulleminot</surname><given-names>P</given-names></name>
<name><surname>Demuth</surname><given-names>S</given-names></name>
<etal/></person-group><article-title>A rise in cases of nitrous oxide abuse: neurological complications and biological findings</article-title><source>J Neurol</source><year>2022</year><volume>269</volume><fpage>577</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">34245346</pub-id>
</element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>J</given-names></name>
<name><surname>Shang</surname><given-names>X</given-names></name></person-group><article-title>Clinical-radiological dissociation in a patient with nitrous oxide-induced subacute combined degeneration: a case report</article-title><source>BMC Neurol</source><year>2020</year><volume>20</volume><fpage>99</fpage><pub-id pub-id-type="pmid">32183721</pub-id>
</element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xiao</surname><given-names>CP</given-names></name>
<name><surname>Ren</surname><given-names>CP</given-names></name>
<name><surname>Cheng</surname><given-names>JL</given-names></name>
<etal/></person-group><article-title>Conventional MRI for diagnosis of subacute combined degeneration (SCD) of the spinal cord due to vitamin B-12 deficiency</article-title><source>Asia Pac J Clin Nutr</source><year>2016</year><volume>25</volume><fpage>34</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">26965759</pub-id>
</element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>CC</given-names></name></person-group><article-title>Neuroimaging in postinfectious demyelination and nutritional disorders of the central nervous system</article-title><source>Neuroimaging Clin N Am</source><year>2011</year><volume>21</volume><fpage>843</fpage><lpage>858</lpage><comment>viii</comment><pub-id pub-id-type="pmid">22032502</pub-id>
</element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lan</surname><given-names>SY</given-names></name>
<name><surname>Kuo</surname><given-names>CY</given-names></name>
<name><surname>Chou</surname><given-names>CC</given-names></name>
<etal/></person-group><article-title>Recreational nitrous oxide abuse related subacute combined degeneration of the spinal cord in adolescents - A case series and literature review</article-title><source>Brain Dev</source><year>2019</year><volume>41</volume><fpage>428</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">30611595</pub-id>
</element-citation></ref></ref-list><ref-list><title>References</title><ref id="R1a"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pugliese</surname><given-names>RS</given-names></name>, <name><surname>Slagle</surname><given-names>EJ</given-names></name>, <name><surname>Oettinger</surname><given-names>GR</given-names></name>, <name><surname>Neuburger</surname><given-names>KJ</given-names></name>, <name><surname>Ambrose</surname><given-names>TM</given-names></name></person-group>. <article-title>Subacute combined degeneration of the spinal cord in a patient abusing nitrous oxide and self-medicating with cyanocobalamin</article-title>. <source>Am J Health Syst Pharm</source>. <year>2015</year>;<volume>72</volume>:<fpage>952</fpage>-<lpage>957</lpage>.<pub-id pub-id-type="pmid">25987690</pub-id>
</mixed-citation></ref><ref id="R2a"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>JL</given-names></name>, <name><surname>Wang</surname><given-names>SK</given-names></name>, <name><surname>Jiang</surname><given-names>T</given-names></name>, <name><surname>Hu</surname><given-names>WL</given-names></name></person-group>. <article-title>Nitrous oxide induced subacute combined degeneration with longitudinally extensive myelopathy with inverted V-sign on spinal MRI: a case report and literature review</article-title>. <source>BMC Neurol</source>. <year>2017</year>;<volume>17</volume>:<fpage>222</fpage>.<pub-id pub-id-type="pmid">29282001</pub-id>
</mixed-citation></ref><ref id="R3a"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Antonucci</surname><given-names>MU</given-names></name></person-group>. <article-title>Subacute combined degeneration from recreational nitrous oxide inhalation</article-title>. <source>J Emerg Med</source>. <year>2018</year>;<volume>54</volume>:<fpage>e105</fpage>-<lpage>e107</lpage>.<pub-id pub-id-type="pmid">29602528</pub-id>
</mixed-citation></ref><ref id="R4a"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>D</given-names></name>, <name><surname>Beecher</surname><given-names>G</given-names></name>, <name><surname>van</surname><given-names>Dijk R</given-names></name>, <name><surname>Hussain</surname><given-names>M</given-names></name>, <name><surname>Siddiqi</surname><given-names>Z</given-names></name>, <name><surname>Ba</surname><given-names>F</given-names></name></person-group>. <article-title>Subacute combined degeneration from nitrous oxide abuse in a patient with pernicious anemia</article-title>. <source>Can J Neurol Sci</source>. <year>2018</year>;<volume>45</volume>:<fpage>334</fpage>-<lpage>335</lpage>.<pub-id pub-id-type="pmid">29756593</pub-id>
</mixed-citation></ref><ref id="R5a"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Choi</surname><given-names>C</given-names></name>, <name><surname>Kim</surname><given-names>T</given-names></name>, <name><surname>Park</surname><given-names>KD</given-names></name>, <name><surname>Lim</surname><given-names>OK</given-names></name>, <name><surname>Lee</surname><given-names>JK</given-names></name></person-group>. <article-title>Subacute combined degeneration caused by nitrous oxide intoxication: a report of two cases</article-title>. <source>Ann Rehabil Med</source>. <year>2019</year>;<volume>43</volume>:<fpage>530</fpage>-<lpage>534</lpage>.<pub-id pub-id-type="pmid">31499607</pub-id>
</mixed-citation></ref><ref id="R6a"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McArdle</surname><given-names>DJT</given-names></name>, <name><surname>Gaillard</surname><given-names>F</given-names></name></person-group>. <article-title>Pernicious azotaemia? A case series of subacute combined degeneration of the cord secondary to nitrous oxide abuse</article-title>. <source>J Clin Neurosci</source>. <year>2020</year>;<volume>72</volume>:<fpage>277</fpage>-<lpage>280</lpage>.<pub-id pub-id-type="pmid">31937498</pub-id>
</mixed-citation></ref><ref id="R7a"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwon</surname><given-names>YJ</given-names></name>, <name><surname>Rho</surname><given-names>JH</given-names></name>, <name><surname>Hwang</surname><given-names>J</given-names></name>, <name><surname>Baek</surname><given-names>SH</given-names></name></person-group>. <article-title>Unhappy end of 'happy balloons': subacute combined degeneration caused by nitrous oxide gas</article-title>. <source>J Clin Neurol</source>. <year>2019</year>;<volume>15</volume>:<fpage>118</fpage>-<lpage>119</lpage>.<pub-id pub-id-type="pmid">30375767</pub-id>
</mixed-citation></ref><ref id="R8a"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chaplin</surname><given-names>K</given-names></name>, <name><surname>Bower</surname><given-names>P</given-names></name>, <name><surname>Man</surname><given-names>MS</given-names></name>, <etal/></person-group>. <article-title>Understanding usual care for patients with multimorbidity: baseline data from a cluster-randomised trial of the 3D intervention in primary care</article-title>. <source>BMJ Open</source>. <year>2018</year>;<volume>8</volume>:<fpage>e019845</fpage>.</mixed-citation></ref><ref id="R9a"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>J</given-names></name>, <name><surname>Shang</surname><given-names>X</given-names></name></person-group>. <article-title>Clinical-radiological dissociation in a patient with nitrous oxide-induced subacute combined degeneration: a case report</article-title>. <source>BMC Neurol</source>. <year>2020</year>;<volume>20</volume>:<fpage>99</fpage>.<pub-id pub-id-type="pmid">32183721</pub-id>
</mixed-citation></ref><ref id="R10a"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Zhao</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Zhao</surname><given-names>R</given-names></name></person-group>. <article-title>Subacute combined degeneration induced by nitrous oxide inhalation: Two case reports</article-title>. <source>Medicine (Baltimore)</source>. <year>2020</year>;<volume>99</volume>:<fpage>e19926</fpage>.<pub-id pub-id-type="pmid">32358361</pub-id>
</mixed-citation></ref><ref id="R11a"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seed</surname><given-names>A</given-names></name>, <name><surname>Jogia</surname><given-names>M</given-names></name></person-group>. <article-title>Lessons of the month: Nitrous oxide-induced functional vitamin B(12) deficiency causing subacute combined degeneration of the spinal cord</article-title>. <source>Clin Med (Lond)</source>. <year>2020</year>;<volume>20</volume>:<fpage>e7</fpage>-<lpage>e9</lpage>.<pub-id pub-id-type="pmid">32414730</pub-id>
</mixed-citation></ref></ref-list></back></article>